BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27630063)

  • 1. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
    Schlaich MP
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
    Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
    Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-based renal sympathectomy.
    Id D; Bertog SC; Wunderlich N; Sievert H
    J Cardiovasc Surg (Torino); 2010 Oct; 51(5):721-39. PubMed ID: 20924332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
    Grassi G; Seravalle G; Brambilla G; Mancia G
    Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns.
    Faselis C; Doumas M; Kokkinos P; Tsioufis C; Papademetriou V
    Curr Vasc Pharmacol; 2014 Jan; 12(1):38-46. PubMed ID: 23905598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
    Ewen S; Ukena C; Böhm M; Mahfoud F
    Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
    [No Abstract]   [Full Text] [Related]  

  • 8. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.
    Hoogerwaard AF; de Jong MR; Elvan A
    Curr Hypertens Rep; 2018 Mar; 20(3):24. PubMed ID: 29556850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of interventional management of hypertension: threats and opportunities.
    Briasoulis A; Bakris G
    Curr Vasc Pharmacol; 2014 Jan; 12(1):69-76. PubMed ID: 23905592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology I: the kidney and the sympathetic nervous system.
    de Jager RL; Blankestijn PJ
    EuroIntervention; 2013 May; 9 Suppl R():R42-7. PubMed ID: 23732154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal denervation in the treatment of resistant arterial hypertension.
    Lambert T; Schützenberger W; Steinwender C
    Wien Med Wochenschr; 2014 Dec; 164(23-24):515-8. PubMed ID: 25394989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation: current implications and future perspectives.
    Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
    Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation in hypertension: Towards a true revival?
    Courand PY; Azizi M; Lantelme P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):541-544. PubMed ID: 30219622
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment.
    Schlaich MP; Kiuchi MG; Esler MD
    Hypertension; 2018 Aug; 72(2):287-290. PubMed ID: 29941510
    [No Abstract]   [Full Text] [Related]  

  • 16. Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation.
    Grassi G; Seravalle G; Brambilla G; Cesana F; Giannattasio C; Mancia G
    Curr Vasc Pharmacol; 2014 Jan; 12(1):63-8. PubMed ID: 23905595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.
    Papademetriou V; Rashidi AA; Tsioufis C; Doumas M
    Circulation; 2014 Apr; 129(13):1440-51. PubMed ID: 24687645
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of the sympathetic nervous system by the kidney.
    Larsen R; Thorp A; Schlaich M
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):61-8. PubMed ID: 24275767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.